Home › Funds › AXIOM INVESTORS LLC /DE › UTHR

AXIOM INVESTORS LLC /DE position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

AXIOM INVESTORS LLC /DE reported holding 57,872 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$31.4M, representing 0.22% of its reported portfolio and ranking #48 among its reported holdings. AXIOM INVESTORS LLC /DE has disclosed UTHR holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)57.87K sh
Reported value held$31.36M
Portfolio Weight0.22%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How AXIOM INVESTORS LLC /DE's UTHR position evolved

AXIOM INVESTORS LLC /DE first disclosed a stake in UTHR in Q3 2023 at 4,425 shares (US$999K). The position peaked in Q3 2026 at 57,872 shares, worth US$31.4M. Across 10 filings, AXIOM INVESTORS LLC /DE increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 57,872 shares valued at US$31.4M — an increase of 3,435 shares quarter over quarter.. Notable position changes include a 95% increase in Q4 2023 (shares rose 4% over the following quarter), a 84% trim in Q1 2025 (shares fell 8% over the following quarter), a 6662% increase in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.42K $999.48K New
Q4 2023 8.63K $1.90M Add
Q1 2024 12.91K $2.97M Add
Q2 2024 13.78K $4.39M Add
Q3 2024 9.19K $3.29M Reduce
Q4 2024 10.04K $3.54M Add
Q1 2025 1.62K $499.71K Reduce
Q1 2026 805 $477.35K New
Q2 2026 54.44K $29.50M Add
Q3 2026 57.87K $31.36M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 39 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has AXIOM INVESTORS LLC /DE held UTHR?

AXIOM INVESTORS LLC /DE has disclosed UTHR holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

What is AXIOM INVESTORS LLC /DE's current position in UTHR?

As of Q3 2026, AXIOM INVESTORS LLC /DE holds 57.87K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $31.36M, representing 0.22% of its reported portfolio and ranking #48.

Has AXIOM INVESTORS LLC /DE been buying or selling UTHR?

In the latest 13F filing (Q3 2026), AXIOM INVESTORS LLC /DE increased its position in UTHR. The position peaked in Q3 2026 at 57.87K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.